The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings - CNBC
As Lilly widens its lead in the obesity race, Novo is still racing to win back market share and restore investor confidence in its pipeline.
Search Group
Share To
Comments
About Screade
Screade® Inc. version 7b1b8de, copyright 2016 - 2026
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments